Edition:
United Kingdom

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

4.82USD
24 Sep 2018
Change (% chg)

-- (--)
Prev Close
$4.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,284
52-wk High
$13.50
52-wk Low
$4.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.046
Mar '18 0.00 -0.028
FY 2017 Dec '17
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
FY 2016 Dec '16 0.00 -0.021
Sep '16 0.00 -0.071
Jun '16 0.00 -0.039
Mar '16 0.00 -0.049
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 2.07 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 12.06 15.51 5.00
Price to Tangible Book (MRQ) 12.39 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.79 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -60.47 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 35.30 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 8.17 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -345.79 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,030 860,305,026
Net Income/Employee (TTM) -- 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -128.02 -0.15 11.13
Return on Assets - 5 Yr. Avg. -46.89 3.51 12.40
Return on Investment (TTM) -144.94 1.79 14.61
Return on Investment - 5 Yr. Avg. -72.71 2.56 16.13
Return on Equity (TTM) -182.75 3.28 16.33
Return on Equity - 5 Yr. Avg. -76.69 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.